The Mark Foundation For Cancer Research is a family office. Team members are concentrated in New York, United States. Among the 7 companies in the known portfolio are Interius BioTherapeutics, Accent Therapeutics, C2i Genomics, Hyku, Immunitas Therapeutics and Vicinitas Therapeutics.
Is The Mark Foundation For Cancer Research a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCancer ResearchDiagnosticsDrug DiscoveryGenomics
Who to pitch at The Mark Foundation For Cancer Research
The Mark Foundation For Cancer Research portfolio companies (7)
- Interius BioTherapeutics
- Accent Therapeutics
- C2i Genomics
- Hyku
- Immunitas Therapeutics
- Vicinitas Therapeutics
- The Jackson Laboratory
Co-investors
Funds that share portfolio companies with The Mark Foundation For Cancer Research.
Similar funds
Showing 20 of 100
About The Mark Foundation For Cancer Research
The firm's listing covers sector Healthcare, and focus areas Biotech, Cancer Research, Diagnostics and Drug Discovery; known deals cluster at Growth, Seed and Series A.
The contacts to approach at The Mark Foundation For Cancer Research are Ryan Schoenfeld (Chief Executive Officer) and Janice Lin (Investor).
The Mark Foundation For Cancer Research shares portfolio companies with 14 other investment firms, among them Alexandria Real Estate Equities, Eisai Innovation and Tellus Bioventures.
Frequently asked questions
What is The Mark Foundation For Cancer Research?
The Mark Foundation For Cancer Research is a family office whose team is concentrated in New York, United States, with a known portfolio of 7 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does The Mark Foundation For Cancer Research invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cancer Research, Diagnostics and Drug Discovery. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does The Mark Foundation For Cancer Research invest at?
The known deals of The Mark Foundation For Cancer Research include Growth, Seed and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at The Mark Foundation For Cancer Research?
Both people on file at The Mark Foundation For Cancer Research are listed as contacts for the firm, each with their own profile page.
How do I contact The Mark Foundation For Cancer Research?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 2 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal